|
Q |
Cia25 |
Collagen induced arthritis QTL 25 |
|
IEA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr12:2,747,694...47,747,694
|
|
Q |
Cia26 |
Collagen induced arthritis QTL 26 |
|
IEA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr18:64,383,762...79,484,311
|
|
Q |
Colcr1 |
Colorectal carcinoma resistance QTL 1 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 4:8,428,551...30,449,094
|
|
Q |
Colcr2 |
Colorectal carcinoma resistance QTL 2 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,315,759...47,315,759
|
|
Q |
Colcr3 |
Colorectal carcinoma resistance QTL 3 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:1...25,022,372
|
|
Q |
Colcr4 |
Colorectal carcinoma resistance QTL4 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:30,937,632...75,937,632
|
|
Q |
Colcr5 |
Colorectal carcinoma resistance QTL 5 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:98,944,780...143,944,780
|
|
Q |
Colcr6 |
Colorectal carcinoma resistance QTL 6 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:83,700,787...108,192,169
|
|
Q |
Colcr7 |
Colorectal carcinoma resistance QTL 7 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr17:2,120,843...22,087,569
|
|
Q |
Colcr8 |
Colorectal carcinoma resistance QTL 8 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:31,990,891...76,990,891
|
|
Q |
Colcr9 |
Colorectal carcinoma resistance QTL 9 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1...33,724,594
|
|
Q |
Colcs1 |
Colorectal carcinoma susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 5:160,071,170...172,129,029
|
|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IEA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:104,262,817...153,890,625
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IEA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:65,846,447...86,134,022
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:145,335,553...189,428,310
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:45,429,709...157,555,683
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:20,859,430...113,082,285
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:55,124,766...172,190,305
|
|
Q |
Ept1 |
Estrogen-induced pituitary tumorigenesis QTL 1 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 6:1...44,788,383
|
|
Q |
Ept10 |
Estrogen-induced pituitary tumorigenesis QTL 10 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
|
|
Q |
Ept13 |
Estrogen-induced pituitary tumorigenesis QTL 13 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:86,622,262...131,622,262
|
|
Q |
Ept2 |
Estrogen-induced pituitary tumorigenesis QTL 2 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:67,641,995...130,815,812
|
|
Q |
Ept5 |
Estrogen-induced pituitary tumorigenesis QTL 5 |
|
IEA |
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 4:100,752,691...179,366,077
|
|
Q |
Ept6 |
Estrogen-induced pituitary tumorigenesis QTL 6 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:6,556,347...51,556,347
|
|
Q |
Ept7 |
Estrogen-induced pituitary tumorigenesis QTL 7 |
|
IEA |
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q |
Ept9 |
Estrogen-induced pituitary tumorigenesis QTL 9 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr10:73,950,353...96,620,293
|
|
Q |
Esta1 |
Estrogen-induced thymic atrophy QTL 1 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr10:21,833,758...61,843,633
|
|
Q |
Esta2 |
Estrogen-induced thymic atrophy QTL 2 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:192,287,802...229,609,668
|
|
Q |
Esta3 |
Estrogen-induced thymic atrophy QTL 3 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:139,067,258...192,287,892
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IEA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:6,922,282...81,330,203
|
|
Q |
Prcr1 |
Prostate cancer resistance QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 2:114,440,891...159,440,891
|
|
Q |
Prcr2 |
Prostate cancer resistance QTL 2 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 1:10,379,492...55,379,492
|
|
Q |
Prcs1 |
Prostate cancer susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr19:31,287,532...51,431,640
|
|
Q |
Prcs2 |
Prostate cancer susceptibility QTL 2 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr20:1...34,066,551
|
|
Q |
Renag1 |
Renal agenesis QTL 1 |
|
IEA |
|
RGD |
PMID:16845468 |
RGD:1580355 |
|
|
Q |
Tescar1 |
Testicular tumor resistance QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:34,618,760...79,618,760
|
|